Evidence map›Paper›PMID 32962505›Full record

ArticleThe Journal of international medical research2020

Serum apolipoprotein A-II and alpha-2-antiplasmin levels in midtrimester can be used as predictors of preterm delivery.

Jianxia Huang, Yuhong Yang, Pei He

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jianxia HuangDepartment of Obstetrics and Gynaecology, Shanghai Baoshan District Integrated Traditional Chinese and Western Medicine Hospital, Shanghai, China.ORCID https://orcid.org/0000-0001-6865-0585
Yuhong YangDepartment of Obstetrics, Hangzhou Women's Hospital, Hangzhou, Zhejiang Province, China.
Pei HeDepartment of Obstetrics, Hangzhou Women's Hospital, Hangzhou, Zhejiang Province, China.ORCID https://orcid.org/0000-0002-6904-5632
Hangzhou Women’s Hospital · CNShanghai Traditional Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify serum protein markers in midtrimester that predict preterm delivery.

methodsA retrospective case-control study randomly selected patients that experienced spontaneous preterm birth and healthy control patients that experienced a normal delivery at term. A proteomic analysis was undertaken using the data-independent acquisition method.

resultsA total of 30 singleton pregnant women were randomly selected from 12 800 pregnant women: 15 women had a spontaneous preterm birth (group Y) and 15 age- and body mass index-matched women gave birth at term (group D). All of the patients provided serum at 15-20 weeks of gestation. A total of 39 differentially expressed proteins were identified. Compared with group D, 24 proteins were upregulated and 15 were downregulated in the preterm group Y. Using Kyoto Encyclopedia of Genes and Genomes pathway enrichment, the 24 upregulated proteins were significantly enriched in the complement and coagulation cascade pathways. Search Tool for the Retrieval of Interacting Genes Furthermore (STRING) analysis showed that apolipoprotein A-II (apoA-II) and alpha-2-antiplasmin (α2-AP), two upregulated proteins, were key nodes in the STRING protein-protein network.

conclusionsThese findings suggest that apoA-II and α2-AP might be new markers for predicting preterm delivery in the midtrimester.

Indexed as

Apolipoprotein A-IIPremature Birthalpha-2-AntiplasminCase-Control StudiesFemaleHumansInfant, NewbornPregnancyPregnancy Trimester, SecondProteomicsRetrospective Studiesalpha-2-AntiplasminApolipoprotein A-IIalpha-2-antiplasminapolipoprotein A-IIbiomarkerPretermproteomics

Identifiers

PMID32962505
PMCPMC7517993
OpenAlexW3088983034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.